首页 > 最新文献

Annals of Thoracic Surgery最新文献

英文 中文
Sex-Specific Troponin and Creatine Kinase Thresholds After Coronary Bypass Surgery. 冠状动脉搭桥手术后不同性别的肌钙蛋白和肌酸激酶阈值。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-07-02 DOI: 10.1016/j.athoracsur.2024.06.019
Leo Pölzl, Matthias Thielmann, Philipp Sterzinger, Felix Nägele, Jakob Hirsch, Michael Graber, Clemens Engler, Jonas Eder, Ronja Lohmann, Sophia Schmidt, Simon Staggl, Samuel Heuts, Hanno Ulmer, Michael Grimm, Elfriede Ruttmann-Ulmer, Nikolaos Bonaros, Johannes Holfeld, Can Gollmann-Tepeköylü

Background: The impact of sex-differences on the release of cardiac biomarkers after coronary artery bypass grafting (CABG) remains unknown. The aim of our study was to (1) investigate the impact of sex-differences in cardiac biomarker release after CABG and (2) determine sex-specific thresholds for high-sensitivity cardiac troponin (hs-cTn) and creatine kinase-myocardial band (CK-MB) associated with 30-day major adverse cardiovascular events (MACE) and mortality.

Methods: A consecutive cohort of 3687 patients, comprising 643 women (17.4%) and 3044 men (82.6%), undergoing CABG from 2008 to 2021 in 2 tertiary university centers with serial postoperative cTn and CK-MB measurement was analyzed. The composite primary outcome was MACE at 30 days. Secondary end points were 30-day mortality and 5-year mortality and MACE. Sex-specific thresholds for cTn and CK-MB were determined.

Results: Lower levels of cTn were found in women after CABG (69.18 vs 77.57 times the upper reference limit [URL]; P < .001). The optimal threshold value for cTn was calculated at 94.36 times the URL for female patients and 206.07 times the URL for male patients to predict 30-day MACE. Female patients missed by a general threshold had increased risk for MACE or death within 30 days (cTn: MACE: odds ratio [OR], 3.78; 95% CI, 1.03-13.08; P = .035; death: OR, 4.98; 95% CI, 1.20-20.61; P = .027; CK-MB: MACE: OR, 10.04; 95% CI, 2.07-48.75; P < .001; death: OR 13.59; 95% CI, 2.66-69.47; P = .002).

Conclusions: We provide evidence for sex-specific differences in the outcome and biomarker release after CABG. Sex-specific cutoffs are necessary for the diagnosis of perioperative myocardial injury to improve outcomes of women after CABG.

背景:冠状动脉旁路移植术(CABG)后,性别差异对心脏生物标志物释放的影响尚不清楚。我们的研究旨在:(a) 调查冠状动脉旁路移植术后性别差异对心脏生物标志物释放的影响;(b) 确定与 30 天主要不良心血管事件(MACE)和死亡率相关的高敏肌钙蛋白(hs-cTn)和肌酸激酶-MB(CK-MB)的性别特异性阈值:分析了2008-2021年期间在两所三级大学中心接受CABG手术的3687名连续队列患者(女性:643人(17.4%);男性:3044人(82.6%)),这些患者术后均接受了连续的cTn和CK-MB测量。复合主要结局是 30 天内的 MACE。次要终点为 30 天死亡率、五年死亡率和 MACE。确定了cTn和CK-MB的性别特异性阈值:结果:CABG术后女性的cTn水平较低(69.18 xURL vs. 77.57 xURL; p结论:我们提供了性别差异对CABG术后女性cTn水平影响的证据:我们提供的证据表明,CABG术后的结果和生物标志物的释放存在性别差异。有必要为围术期心肌损伤的诊断设定特定性别的临界值,以改善女性接受 CABG 术后的预后。
{"title":"Sex-Specific Troponin and Creatine Kinase Thresholds After Coronary Bypass Surgery.","authors":"Leo Pölzl, Matthias Thielmann, Philipp Sterzinger, Felix Nägele, Jakob Hirsch, Michael Graber, Clemens Engler, Jonas Eder, Ronja Lohmann, Sophia Schmidt, Simon Staggl, Samuel Heuts, Hanno Ulmer, Michael Grimm, Elfriede Ruttmann-Ulmer, Nikolaos Bonaros, Johannes Holfeld, Can Gollmann-Tepeköylü","doi":"10.1016/j.athoracsur.2024.06.019","DOIUrl":"10.1016/j.athoracsur.2024.06.019","url":null,"abstract":"<p><strong>Background: </strong>The impact of sex-differences on the release of cardiac biomarkers after coronary artery bypass grafting (CABG) remains unknown. The aim of our study was to (1) investigate the impact of sex-differences in cardiac biomarker release after CABG and (2) determine sex-specific thresholds for high-sensitivity cardiac troponin (hs-cTn) and creatine kinase-myocardial band (CK-MB) associated with 30-day major adverse cardiovascular events (MACE) and mortality.</p><p><strong>Methods: </strong>A consecutive cohort of 3687 patients, comprising 643 women (17.4%) and 3044 men (82.6%), undergoing CABG from 2008 to 2021 in 2 tertiary university centers with serial postoperative cTn and CK-MB measurement was analyzed. The composite primary outcome was MACE at 30 days. Secondary end points were 30-day mortality and 5-year mortality and MACE. Sex-specific thresholds for cTn and CK-MB were determined.</p><p><strong>Results: </strong>Lower levels of cTn were found in women after CABG (69.18 vs 77.57 times the upper reference limit [URL]; P < .001). The optimal threshold value for cTn was calculated at 94.36 times the URL for female patients and 206.07 times the URL for male patients to predict 30-day MACE. Female patients missed by a general threshold had increased risk for MACE or death within 30 days (cTn: MACE: odds ratio [OR], 3.78; 95% CI, 1.03-13.08; P = .035; death: OR, 4.98; 95% CI, 1.20-20.61; P = .027; CK-MB: MACE: OR, 10.04; 95% CI, 2.07-48.75; P < .001; death: OR 13.59; 95% CI, 2.66-69.47; P = .002).</p><p><strong>Conclusions: </strong>We provide evidence for sex-specific differences in the outcome and biomarker release after CABG. Sex-specific cutoffs are necessary for the diagnosis of perioperative myocardial injury to improve outcomes of women after CABG.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"120-128"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141535927","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beyond Static Planning: Computational Predictive Modeling to Avoid Coronary Artery Occlusion in TAVR. 超越静态规划:在 TAVR 中避免冠状动脉闭塞的计算预测模型。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-06-18 DOI: 10.1016/j.athoracsur.2024.05.041
Kimberly Holst, Taylor Becker, J Trent Magruder, Pradeep Yadav, James Stewart, Vivek Rajagopal, Shizhen Liu, Venkateshwar Polsani, Lakshmi Prasad Dasi, Vinod H Thourani

Background: Coronary artery occlusion (CO) during transcatheter aortic valve replacement (TAVR) is a devastating complication. The objective of this study was to assess the clinical impact of a computational predictive modeling algorithm for CO during TAVR planning.

Methods: From January 2020 to December 2022, 116 patients (7.6%) who underwent TAVR evaluation were deemed to be at increased risk of CO on the basis of traditional criteria. Patients underwent prospective computational modeling (DASI Simulations) to assess their risk of CO during TAVR; procedural modifications and clinical results were reviewed retrospectively.

Results: Of the 116 patients at risk for CO by traditional methodology, 53 had native aortic valve stenosis (45.7%), 47 had undergone previous surgical AVR (40.5%), and 16 had undergone previous TAVR (13.8%). Transcatheter valve choice, size, or implantation depth was modeled for all patients. Computational modeling predicted an increased risk of CO in 39 of 116 (31.9%) patients. Within this subcohort, 29 patients proceeded with TAVR. Procedural modifications to augment the risk of CO included bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction during TAVR (n = 10), chimney coronary stents (n = 8), and coronary access without stents (n = 3). There were no episodes of coronary artery compromise among patients after TAVR, either for those predicted to be at high risk of CO (with procedural modifications) or those predicted to be at low risk (standard TAVR).

Conclusions: The use of preoperative simulations for TAVR in patient-specific geometry through computational predictive modeling of CO is an effective enhancement to procedure planning.

背景:经导管主动脉瓣置换术(TAVR)中的冠状动脉闭塞(CO)是一种破坏性并发症。我们的目的是评估一种新型计算预测建模算法对 TAVR 计划期间冠状动脉闭塞的临床影响:从 2020 年 1 月到 2022 年 12 月,根据传统标准,有 116 例(7.6%)接受 TAVR 评估的患者被认为 CO 风险增加。患者接受了前瞻性计算建模(DASI 模拟),以评估 TAVR 期间 CO 的风险;对程序修改和临床结果进行了回顾性审查:结果:在采用传统方法评估 CO 风险的 116 名患者中,53 人患有原发性主动脉瓣狭窄(45.7%),47 人既往接受过手术 AVR(40.5%),16 人既往接受过 TAVR(13.8%)。对所有患者的经导管瓣膜选择、大小和/或植入深度进行了建模。计算建模预测,39/116 例患者(31.9%)的 CO 风险增加。在该亚队列中,29 名患者接受了 TAVR。增加CO风险的程序修改包括BASILICA(10例)、烟囱冠状动脉支架(8例)、无支架冠状动脉入路(3例)。在TAVR术后,无论是预测为CO高风险的患者(进行了程序修改),还是预测为低风险的患者(标准TAVR),都没有发生冠状动脉受损的情况:结论:通过对CO进行计算预测建模,利用术前模拟患者特异性几何形状的TAVR能有效改善手术规划。
{"title":"Beyond Static Planning: Computational Predictive Modeling to Avoid Coronary Artery Occlusion in TAVR.","authors":"Kimberly Holst, Taylor Becker, J Trent Magruder, Pradeep Yadav, James Stewart, Vivek Rajagopal, Shizhen Liu, Venkateshwar Polsani, Lakshmi Prasad Dasi, Vinod H Thourani","doi":"10.1016/j.athoracsur.2024.05.041","DOIUrl":"10.1016/j.athoracsur.2024.05.041","url":null,"abstract":"<p><strong>Background: </strong>Coronary artery occlusion (CO) during transcatheter aortic valve replacement (TAVR) is a devastating complication. The objective of this study was to assess the clinical impact of a computational predictive modeling algorithm for CO during TAVR planning.</p><p><strong>Methods: </strong>From January 2020 to December 2022, 116 patients (7.6%) who underwent TAVR evaluation were deemed to be at increased risk of CO on the basis of traditional criteria. Patients underwent prospective computational modeling (DASI Simulations) to assess their risk of CO during TAVR; procedural modifications and clinical results were reviewed retrospectively.</p><p><strong>Results: </strong>Of the 116 patients at risk for CO by traditional methodology, 53 had native aortic valve stenosis (45.7%), 47 had undergone previous surgical AVR (40.5%), and 16 had undergone previous TAVR (13.8%). Transcatheter valve choice, size, or implantation depth was modeled for all patients. Computational modeling predicted an increased risk of CO in 39 of 116 (31.9%) patients. Within this subcohort, 29 patients proceeded with TAVR. Procedural modifications to augment the risk of CO included bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction during TAVR (n = 10), chimney coronary stents (n = 8), and coronary access without stents (n = 3). There were no episodes of coronary artery compromise among patients after TAVR, either for those predicted to be at high risk of CO (with procedural modifications) or those predicted to be at low risk (standard TAVR).</p><p><strong>Conclusions: </strong>The use of preoperative simulations for TAVR in patient-specific geometry through computational predictive modeling of CO is an effective enhancement to procedure planning.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"145-151"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141433295","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Left Atrioventricular Valve Regurgitation After Atrioventricular Septal Defect Repair. 房室隔缺损修复术后左房室瓣反流
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-07-25 DOI: 10.1016/j.athoracsur.2024.07.014
Arif Selcuk, Christopher Spurney, Mahmut Ozturk, Mitchell Haverty, Aybala Tongut, Manan Desai, In Hye Park, Rittal Mehta, Can Yerebakan, Yves d'Udekem

Background: Whether patients with moderate left atrioventricular valve regurgitation (LAVVR) after surgical repair of complete atrioventricular septal defect (CAVSD) should be observed or undergo reoperation remains unclear.

Methods: Moderate LAVVR was diagnosed in 87 of 220 patients who underwent CAVSD repair: 47 during the initial hospital stay and 40 after a median of 7 months (interquartile range, 2-18 months) after the initial operation.

Results: Of these 87 patients who had moderate LAVVR, 15 died, for an overall mortality of 17%. The regurgitation became severe in 39 patients (45%) within a median of 2 months (interquartile range, 1-7 months) leading to 33 reoperations and 10 deaths. In 23 of 87 patients (26%), regurgitation remained at a moderate level over a median follow-up period of 8 months (interquartile range, 1-48 months). In 25 of 87 patients (29%), the regurgitation decreased to mild after a median of 9 months (interquartile range, 5-19 months). The only independent risk factor for increased severity of regurgitation and reoperation was the echocardiographic appearance of the jet centered around the cleft rather than central at the time of diagnosis of moderate regurgitation (odds ratio, 3.5; 95% CI, 1.5-9.0; P = .007).

Conclusions: Moderate LAVVR after CAVSD repair is often linked to death and reoperation, but regurgitation remains stable in one-quarter of patients and improves in one-third. The deterioration usually occurs within the first year after surgery. The initial observation of patients with residual or new moderate regurgitation for up to 1 year or until further deterioration seems reasonable, as long as the regurgitation is centrally located.

背景:完全性房室间隔缺损(CAVSD)手术修复后出现中度左房室瓣反流(LAVVR)的患者是应该观察还是重新手术,目前仍不清楚:在220例接受CAVSD修补术的患者中,共有87例被诊断为中度LAVVR:47例在首次住院期间,40例在首次手术后中位数7个月(IQR:2-18个月)后:结果:87名中度LAVVR患者中有15人死亡,总死亡率为17%。39名患者(45%,39/87)在中位数2个月(1-7个月)内出现严重反流,导致33人再次手术,10人死亡。23名患者(26%,23/87)在中位 8 个月(1-48)的随访期间,反流仍处于中度水平。25名患者(29%,25/87)的反流在中位 9 个月(5-19)后降至轻度。导致反流严重程度增加和再次手术的唯一独立危险因素是,在诊断中度反流时,超声心动图显示的射流以裂隙为中心,而不是以中央为中心(OR:3.5;95%CI:1.5-9.0;P=0.007):结论:CAVSD修复术后中度LAVVR通常与死亡和再次手术有关,但四分之一的患者反流情况保持稳定,三分之一的患者反流情况有所改善。病情恶化通常发生在术后第一年内。只要反流位于中心位置,对残留或新出现中度反流的患者进行长达一年的初步观察或直到病情进一步恶化似乎是合理的。
{"title":"Left Atrioventricular Valve Regurgitation After Atrioventricular Septal Defect Repair.","authors":"Arif Selcuk, Christopher Spurney, Mahmut Ozturk, Mitchell Haverty, Aybala Tongut, Manan Desai, In Hye Park, Rittal Mehta, Can Yerebakan, Yves d'Udekem","doi":"10.1016/j.athoracsur.2024.07.014","DOIUrl":"10.1016/j.athoracsur.2024.07.014","url":null,"abstract":"<p><strong>Background: </strong>Whether patients with moderate left atrioventricular valve regurgitation (LAVVR) after surgical repair of complete atrioventricular septal defect (CAVSD) should be observed or undergo reoperation remains unclear.</p><p><strong>Methods: </strong>Moderate LAVVR was diagnosed in 87 of 220 patients who underwent CAVSD repair: 47 during the initial hospital stay and 40 after a median of 7 months (interquartile range, 2-18 months) after the initial operation.</p><p><strong>Results: </strong>Of these 87 patients who had moderate LAVVR, 15 died, for an overall mortality of 17%. The regurgitation became severe in 39 patients (45%) within a median of 2 months (interquartile range, 1-7 months) leading to 33 reoperations and 10 deaths. In 23 of 87 patients (26%), regurgitation remained at a moderate level over a median follow-up period of 8 months (interquartile range, 1-48 months). In 25 of 87 patients (29%), the regurgitation decreased to mild after a median of 9 months (interquartile range, 5-19 months). The only independent risk factor for increased severity of regurgitation and reoperation was the echocardiographic appearance of the jet centered around the cleft rather than central at the time of diagnosis of moderate regurgitation (odds ratio, 3.5; 95% CI, 1.5-9.0; P = .007).</p><p><strong>Conclusions: </strong>Moderate LAVVR after CAVSD repair is often linked to death and reoperation, but regurgitation remains stable in one-quarter of patients and improves in one-third. The deterioration usually occurs within the first year after surgery. The initial observation of patients with residual or new moderate regurgitation for up to 1 year or until further deterioration seems reasonable, as long as the regurgitation is centrally located.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"160-168"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Representation of Women Moderators at The Society of Thoracic Surgeons Annual Meeting. 胸外科医师学会年会上女主持人的代表性。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-07-25 DOI: 10.1016/j.athoracsur.2024.07.015
Rajika Jindani, Justin Olivera, Jorge Humberto Rodriguez-Quintero, Patricia Friedmann, Marc Vimolratana, Neel Chudgar, Mara B Antonoff, Brendon Stiles

Background: Recently, there has been an increase in the representation of women within the cardiothoracic surgery workforce, with discussions about gender equity garnering interest. We sought to identify whether this increase is accompanied by commensurate selection for representation at national meetings.

Methods: Online archives of The Society of Thoracic Surgeons (STS) Annual Meetings were reviewed from 2015 to 2024. Data regarding the moderator's gender were abstracted. The gender distribution of moderators across the various session categories was surveyed, and subgroup analyses were performed.

Results: During the years of study, the STS Annual Meeting Taskforce selected 983 moderators to participate in the conference, including 218 women. The representation of women moderators demonstrated a favorable, upward trend. In 2015, 12.1% of moderators were women, with a consistent rate from 2015 to 2018. There was a noticeable rise in invited women moderators in 2019, with 25.4% of moderators being women. This proportion increased to 36.9% women in 2024. General Thoracic sessions have consistently included a greater percentage of women moderators compared with other sessions. Other topic areas, such as Education and Quality Improvement and Critical Care, transitioned to greater representation of women in recent years.

Conclusions: There has been an increase over time in women moderators selected for participation in the STS Annual Meeting, with progress in gender diversity seen in most session types. Although the overall proportion of women within cardiothoracic surgery remains low, the STS has increasingly worked toward encouraging inclusivity. Efforts to further support well-rounded representation are of important benefit.

背景:最近,心胸外科工作队伍中的女性人数有所增加,有关性别平等的讨论引起了人们的关注。我们试图确定这一增长是否伴随着在全国性会议上对代表的相应选择:我们查阅了 2015 年至 2024 年胸外科医师学会(STS)年会的在线档案。摘录了有关主持人性别的数据。调查了不同会议类别中主持人的性别分布情况,并进行了分组分析:在研究期间,STS年会工作组共选出983名主持人参加会议,其中包括218名女性。女性主持人的比例呈现出良好的上升趋势。2015年,12.1%的主持人为女性,从2015年到2018年,这一比例一直保持不变。2019 年,受邀的女性主持人明显增多,女性主持人占 25.4%。2024 年,这一比例增至 36.9%。与其他会议相比,普通胸科会议的女性主持人比例一直较高。其他主题领域,如教育与质量改进和重症监护,近年来女性的比例也有所提高:结论:随着时间的推移,被选中参加 STS 年会的女性主持人越来越多,大多数会议类型在性别多样性方面都取得了进展。虽然心胸外科中女性的总体比例仍然较低,但 STS 已越来越多地致力于鼓励包容性。进一步支持全面代表性的努力具有重要的益处。
{"title":"The Representation of Women Moderators at The Society of Thoracic Surgeons Annual Meeting.","authors":"Rajika Jindani, Justin Olivera, Jorge Humberto Rodriguez-Quintero, Patricia Friedmann, Marc Vimolratana, Neel Chudgar, Mara B Antonoff, Brendon Stiles","doi":"10.1016/j.athoracsur.2024.07.015","DOIUrl":"10.1016/j.athoracsur.2024.07.015","url":null,"abstract":"<p><strong>Background: </strong>Recently, there has been an increase in the representation of women within the cardiothoracic surgery workforce, with discussions about gender equity garnering interest. We sought to identify whether this increase is accompanied by commensurate selection for representation at national meetings.</p><p><strong>Methods: </strong>Online archives of The Society of Thoracic Surgeons (STS) Annual Meetings were reviewed from 2015 to 2024. Data regarding the moderator's gender were abstracted. The gender distribution of moderators across the various session categories was surveyed, and subgroup analyses were performed.</p><p><strong>Results: </strong>During the years of study, the STS Annual Meeting Taskforce selected 983 moderators to participate in the conference, including 218 women. The representation of women moderators demonstrated a favorable, upward trend. In 2015, 12.1% of moderators were women, with a consistent rate from 2015 to 2018. There was a noticeable rise in invited women moderators in 2019, with 25.4% of moderators being women. This proportion increased to 36.9% women in 2024. General Thoracic sessions have consistently included a greater percentage of women moderators compared with other sessions. Other topic areas, such as Education and Quality Improvement and Critical Care, transitioned to greater representation of women in recent years.</p><p><strong>Conclusions: </strong>There has been an increase over time in women moderators selected for participation in the STS Annual Meeting, with progress in gender diversity seen in most session types. Although the overall proportion of women within cardiothoracic surgery remains low, the STS has increasingly worked toward encouraging inclusivity. Efforts to further support well-rounded representation are of important benefit.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"227-234"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141789821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Multi-arterial Bypass Graft: Need for Quality RCTs to Evaluate Elaborate Operative Characteristics. 多动脉旁路移植术的结果:需要高质量的 RCT 来评估精细的手术特点。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-10-16 DOI: 10.1016/j.athoracsur.2024.09.046
Mana Jameie, Mina Pashang, Kiomars Abbasi, Kaveh Hosseini, Mario Gaudino
{"title":"Outcomes of Multi-arterial Bypass Graft: Need for Quality RCTs to Evaluate Elaborate Operative Characteristics.","authors":"Mana Jameie, Mina Pashang, Kiomars Abbasi, Kaveh Hosseini, Mario Gaudino","doi":"10.1016/j.athoracsur.2024.09.046","DOIUrl":"10.1016/j.athoracsur.2024.09.046","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"247-248"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142480078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aortic Valve Repair in Real World. . . We Can Do Better. 主动脉瓣修复在现实世界…我们可以做得更好。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-08-13 DOI: 10.1016/j.athoracsur.2024.07.030
Marek J Jasinski
{"title":"Aortic Valve Repair in Real World. . . We Can Do Better.","authors":"Marek J Jasinski","doi":"10.1016/j.athoracsur.2024.07.030","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2024.07.030","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 1","pages":"248-250"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142866143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Harmonizing Guidelines and Other Clinical Practice Documents: A Joint Comprehensive Methodology Manual by the American Association for Thoracic Surgery (AATS), European Association for Cardio-Thoracic Surgery (EACTS), European Society of Thoracic Surgeons (ESTS), and Society of Thoracic Surgeons (STS). 协调指南和其他临床实践文件:美国胸外科协会 (AATS)、欧洲心胸外科学会 (EACTS)、欧洲胸外科医师学会 (ESTS) 和胸外科医师学会 (STS) 联合编写的《综合方法手册》。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-10-22 DOI: 10.1016/j.athoracsur.2024.09.023
Milan Milojevic, Nick Freemantle, J W Awori Hayanga, Rosemary F Kelly, Patrick O Myers, René Horsleben Petersen, Isabelle Opitz, Joseph F Sabik, Faisal G Bakaeen
{"title":"Harmonizing Guidelines and Other Clinical Practice Documents: A Joint Comprehensive Methodology Manual by the American Association for Thoracic Surgery (AATS), European Association for Cardio-Thoracic Surgery (EACTS), European Society of Thoracic Surgeons (ESTS), and Society of Thoracic Surgeons (STS).","authors":"Milan Milojevic, Nick Freemantle, J W Awori Hayanga, Rosemary F Kelly, Patrick O Myers, René Horsleben Petersen, Isabelle Opitz, Joseph F Sabik, Faisal G Bakaeen","doi":"10.1016/j.athoracsur.2024.09.023","DOIUrl":"10.1016/j.athoracsur.2024.09.023","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"83-100"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142512384","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What's the Game Plan, Coach? Preparation and Triage Are Key for HLHS Management. 游戏计划是什么,教练?准备和分诊是 HLHS 管理的关键。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-06-17 DOI: 10.1016/j.athoracsur.2024.06.007
Neel K Prabhu, Douglas M Overbey, Joseph W Turek
{"title":"What's the Game Plan, Coach? Preparation and Triage Are Key for HLHS Management.","authors":"Neel K Prabhu, Douglas M Overbey, Joseph W Turek","doi":"10.1016/j.athoracsur.2024.06.007","DOIUrl":"10.1016/j.athoracsur.2024.06.007","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"178-179"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141428216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors. 对于以玻璃钙化为主的小肿瘤,可省略淋巴结清扫。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-03-19 DOI: 10.1016/j.athoracsur.2024.03.013
Takahiro Mimae, Yoshihiro Miyata, Norifumi Tsubokawa, Yujin Kudo, Takuya Nagashima, Hiroyuki Ito, Norihiko Ikeda, Morihito Okada

Background: The purpose of this study was to determine the optimal extent of lymph node dissection required in patients with small (≤3 cm) radiologically ground-glass opacity-dominant, peripheral, non-small cell lung cancer tumors.

Methods: The study analyzed the clinicopathologic findings and surgical outcomes of 988 patients with radiologic, ground-glass opacity-dominant non-small cell lung cancer without lymph node involvement who underwent complete resection of the primary tumor between 2010 and 2020. Patients were followed up for 54.5 months (median). Kaplan-Meier curves and the log-rank test were used in statistical analyses of the prognosis.

Results: Median age, whole tumor size, solid tumor size, and maximum standardized uptake values were 68 years, 1.7 cm, 0.4 cm, and 0.9, respectively. Sixty percent of the cohort was female (n = 590). Wedge resection, segmentectomy, and lobectomy were performed in 206, 372, and 410 patients, respectively. A total of 982 of 988 (99%) tumors were adenocarcinomas. One patient had hilar lymph node involvement; however, no mediastinal lymph node metastasis or hilar or mediastinal lymph node recurrence was detected. The 5-year overall survival rate was 96.5% (95% CI, 94.8%-97.7%). Excellent survival outcomes were achieved regardless of procedure (wedge resection, 94.7% [95% CI, 89.1%-97.5%]; segmentectomy, 96.9% [95% CI, 93.7%-98.5%]; and lobectomy, 97.1% [95% CI, 94.4%-98.5%]).

Conclusions: Omitting lymph node dissection may be acceptable with curative intent for small tumors with radiologic ground-glass opacity dominance. Appropriate surgical procedures such as wedge resection, segmentectomy, or lobectomy can provide satisfactory outcomes in patients with indolent tumors if surgical margins are secured.

研究背景研究目的是确定放射学显示为磨玻璃不透明为主的周围型非小细胞肺癌小肿瘤(≤ 3 厘米)患者所需的最佳淋巴结清扫范围:我们分析了2010年至2020年间988名放射学上以磨玻璃不透明为主的非小细胞肺癌患者的临床病理结果/手术疗效,这些患者均接受了原发肿瘤的完全切除术,且无淋巴结受累。患者的随访时间为 54.5 个月(中位数)。采用卡普兰-梅耶曲线和对数秩检验对预后进行统计分析:中位年龄、整个肿瘤大小、实体瘤大小和最大标准化摄取值分别为68岁、1.7厘米、0.4厘米和0.9。60%的患者为女性(n = 590)。分别有206、372和410名患者接受了楔形切除术、分段切除术和肺叶切除术。988 例肿瘤中有 982 例(99%)为腺癌。一名患者的肺门淋巴结受累,但未发现纵隔淋巴结转移或肺门或纵隔淋巴结复发。五年总生存率为 96.5%(95% 置信区间:94.8 - 97.7%)。无论采用哪种手术(楔形切除术,94.7% [95% CI:89.1 - 97.5%];分段切除术,96.9% [95% CI:93.7 - 98.5%];肺叶切除术,97.1% [95% CI:94.4 - 98.5%]),都取得了很好的生存效果:结论:对于放射学显示为磨玻璃不透明的小肿瘤,可以接受不进行淋巴结清扫,以达到治愈目的。楔形切除术、分段切除术或肺叶切除术等适当的手术方法在确保手术切缘的情况下,可为不显性肿瘤患者提供满意的治疗效果。
{"title":"Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors.","authors":"Takahiro Mimae, Yoshihiro Miyata, Norifumi Tsubokawa, Yujin Kudo, Takuya Nagashima, Hiroyuki Ito, Norihiko Ikeda, Morihito Okada","doi":"10.1016/j.athoracsur.2024.03.013","DOIUrl":"10.1016/j.athoracsur.2024.03.013","url":null,"abstract":"<p><strong>Background: </strong>The purpose of this study was to determine the optimal extent of lymph node dissection required in patients with small (≤3 cm) radiologically ground-glass opacity-dominant, peripheral, non-small cell lung cancer tumors.</p><p><strong>Methods: </strong>The study analyzed the clinicopathologic findings and surgical outcomes of 988 patients with radiologic, ground-glass opacity-dominant non-small cell lung cancer without lymph node involvement who underwent complete resection of the primary tumor between 2010 and 2020. Patients were followed up for 54.5 months (median). Kaplan-Meier curves and the log-rank test were used in statistical analyses of the prognosis.</p><p><strong>Results: </strong>Median age, whole tumor size, solid tumor size, and maximum standardized uptake values were 68 years, 1.7 cm, 0.4 cm, and 0.9, respectively. Sixty percent of the cohort was female (n = 590). Wedge resection, segmentectomy, and lobectomy were performed in 206, 372, and 410 patients, respectively. A total of 982 of 988 (99%) tumors were adenocarcinomas. One patient had hilar lymph node involvement; however, no mediastinal lymph node metastasis or hilar or mediastinal lymph node recurrence was detected. The 5-year overall survival rate was 96.5% (95% CI, 94.8%-97.7%). Excellent survival outcomes were achieved regardless of procedure (wedge resection, 94.7% [95% CI, 89.1%-97.5%]; segmentectomy, 96.9% [95% CI, 93.7%-98.5%]; and lobectomy, 97.1% [95% CI, 94.4%-98.5%]).</p><p><strong>Conclusions: </strong>Omitting lymph node dissection may be acceptable with curative intent for small tumors with radiologic ground-glass opacity dominance. Appropriate surgical procedures such as wedge resection, segmentectomy, or lobectomy can provide satisfactory outcomes in patients with indolent tumors if surgical margins are secured.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"192-198"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140186218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lifetime Management of Adolescents and Young Adults with Congenital Aortic Valve Disease. 对患有先天性主动脉瓣疾病的青少年的终生管理。
IF 3.6 2区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-01-01 Epub Date: 2024-06-11 DOI: 10.1016/j.athoracsur.2024.04.038
William C Frankel, Justin A Robinson, Eric E Roselli, Shinya Unai, Justin T Tretter, Stephanie Fuller, Jennifer S Nelson, Joanna Ghobrial, Lars G Svensson, Gösta B Pettersson, Hani K Najm, Tara Karamlou

In this invited expert review, we focus on evolving lifetime management strategies for adolescents and young adults with congenital aortic valve disease, acknowledging that these patients often require multiple interventions during their lifetime. Our goal is to preserve the native aortic valve when feasible. Leveraging advanced multimodality imaging, a detailed assessment of the aortic valve and root complex can be obtained, and a surgically approach tailored to an individual patient's anatomy and pathology can be used. In turn, aortic valve repair and reconstruction can be offered to a greater number of patients, either as a definitive strategy or as a component of a staged strategy to delay the need for aortic valve replacement until later in life when more options are available.

在这篇特邀专家综述中,我们将重点关注患有先天性主动脉瓣疾病的青少年和年轻成人的终生管理策略的演变,因为我们认识到这些患者在其一生中往往需要多次介入治疗。我们的目标是在可行的情况下保留原生主动脉瓣。利用先进的多模态成像技术,可以对主动脉瓣和瓣根复合体进行详细评估,并根据患者的解剖结构和病理情况量身定制手术方法。反过来,主动脉瓣修复和重建也可以作为一种明确的策略或分阶段策略的一部分提供给更多的患者,将主动脉瓣置换的需要推迟到晚年,因为晚年有更多的选择。对于患有无法修复的主动脉瓣疾病的青少年和年轻人,我们的首选策略是用肺自体移植(Ross 手术)或自体心包(Ozaki 手术)进行主动脉瓣置换。使用生物人工瓣膜或机械瓣膜进行主动脉瓣置换术是一种安全、可重复的选择,是青少年和年轻成人的 "最后手段",因为瓣膜相关并发症的终生累积风险以及这些患者在随访期间的持续流失。
{"title":"Lifetime Management of Adolescents and Young Adults with Congenital Aortic Valve Disease.","authors":"William C Frankel, Justin A Robinson, Eric E Roselli, Shinya Unai, Justin T Tretter, Stephanie Fuller, Jennifer S Nelson, Joanna Ghobrial, Lars G Svensson, Gösta B Pettersson, Hani K Najm, Tara Karamlou","doi":"10.1016/j.athoracsur.2024.04.038","DOIUrl":"10.1016/j.athoracsur.2024.04.038","url":null,"abstract":"<p><p>In this invited expert review, we focus on evolving lifetime management strategies for adolescents and young adults with congenital aortic valve disease, acknowledging that these patients often require multiple interventions during their lifetime. Our goal is to preserve the native aortic valve when feasible. Leveraging advanced multimodality imaging, a detailed assessment of the aortic valve and root complex can be obtained, and a surgically approach tailored to an individual patient's anatomy and pathology can be used. In turn, aortic valve repair and reconstruction can be offered to a greater number of patients, either as a definitive strategy or as a component of a staged strategy to delay the need for aortic valve replacement until later in life when more options are available.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":"59-69"},"PeriodicalIF":3.6,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141318926","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of Thoracic Surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1